PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital (CHU), 37 Allées Jules Guesde, 31000, Toulouse, France.\', \'Department of Child and Adolescent Psychiatry, Faculty of Medicine, Toulouse University Hospital (CHU), Toulouse, France.\', \'UMR 1027 Pharmacoepidemiology, Assessment of Drug Utilization and Drug Safety, INSERM, CIC 1426, University Paul Sabatier Toulouse, Toulouse, France.\', \'Department of Medical Psychiatry, Toulouse University Hospital (CHU), Faculty of Medicine, Treatment Resistant Depression Expert Center, FondaMental, ToNIC Toulouse NeuroImaging Center, University Paul Sabatier Toulouse, INSERM, Toulouse, France.\', \'Department of Rheumatology, Faculty of Medicine, Toulouse University Hospital (CHU), Toulouse, France.\', \'Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital (CHU), 37 Allées Jules Guesde, 31000, Toulouse, France. francois.montastruc@univ-tlse3.fr.\', \'UMR 1027 Pharmacoepidemiology, Assessment of Drug Utilization and Drug Safety, INSERM, CIC 1426, University Paul Sabatier Toulouse, Toulouse, France. francois.montastruc@univ-tlse3.fr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s40264-020-01013-3
?:doi
?:hasPublicationType
?:journal
  • Drug safety
is ?:pmid of
?:pmid
?:pmid
  • 33078372
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.447
?:rankingScore_hIndex
  • 112
is ?:relation_isRelatedTo_publication of
?:title
  • Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all